Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 15 hours agoModerna has announced that its Phase III clinical trial of the investigational next-generation...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 1 day agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial
Clinical Trials Arena via Yahoo Finance· 13 hours agoAldeyra Therapeutics has concluded the subject enrolment in its Phase III clinical trial of topical...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails -...
Benzinga· 6 hours agoPfizer's PFE phase III study of investigational gene therapy, fordadistrogene movaparvovec, for...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 2 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna has announced positive Phase III data for its Covid-19/influenza combination vaccine,...
Takeda signs option agreement with Ascentage for CML drug
Pharmaceutical Technology via Yahoo Finance· 7 hours agoUnder the terms of the agreement, Ascentage will continue to be solely responsible for all clinical...
Viridian Therapeutics to begin Phase III trials of thyroid eye disease treatment
Clinical Trials Arena via Yahoo Finance· 3 days agoUS-based biotechnology company Viridian Therapeutics has announced plans to begin two Phase III...
Friday Dance Music Guide: The Week’s Best New Tracks From Tokimonsta, SG Lewis & Tove Lo, Sofi...
Billboard via Yahoo News· 5 hours agoA singalong anthem about a relationship in its downward trajectory phase, the song is built around...
Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry
Zacks· 18 hours agoIntellia's (NTLA) lead genome-editing candidate, NTLA-2001 being developed to treat transthyretin (ATTR) amyloidosis, holds promise. Other pipeline candidates are also progressing well.